Ramona Optics Closes $25M to Scale Imaging Systems
Ramona Optics raised $25M Series A led by Arch Venture Partners to scale commercial operations and advance its MCAM technology.
The big picture: Durham, N.C.-based Ramona Optics, which develops imaging systems for biopharma and biomedical use, has closed an oversubscribed $25 million Series A financing round.
Why it matters:
- Quantitative Data: Traditional microscopes are designed for human observation, lacking the quantitative data necessary for modern drug discovery and accurate diagnoses. Ramona’s MCAM technology is built for computation, enabling statistically meaningful data extraction.
- High-Throughput Discovery: The company’s multi-camera array microscopes (MCAMs) overcome the traditional trade-off between field-of-view and resolution, allowing for high-throughput drug discovery experiments.
- AI-Driven Insights: By generating massive, high-definition datasets, Ramona’s technology enables AI to extract insights that are beyond the scope of human observation, accelerating biological understanding and therapeutic development.
How it works:
- MCAM Technology: Ramona Optics has developed a fundamentally new class of microscopy technology, utilizing multi-camera array microscopes for massively parallel imaging and on-the-fly analysis.
- Commercial Adoption: These proprietary systems are already being adopted by customers in both academia and industry, demonstrating their practical utility and market readiness.
- Expertise and IP: The company holds 29 patents and employs 12 PhD holders with expertise spanning computational imaging, machine learning, computer architecture, cancer biology, and neuroscience.
The catch: The biopharma imaging market is highly competitive, with established players and continuous innovation in microscopy and AI-driven analytics. Ramona Optics will need to demonstrate sustained differentiation and robust commercial execution to scale its operations and penetrate a market that demands both cutting-edge technology and proven reliability.
Key Facts
- Company: Ramona Optics
- Amount: $25M
- Round: Series A
- Investors: Arch Venture Partners (lead), Stealthpoint Ventures, ND Capital, Fall Line Capital, Hamamatsu Ventures, Murchison Capital Partners, Overlap Holdings
- Founders: Gregor Horstmeyer, Mark Harfouche, Roarke Horstmeyer
- Sector: Biopharma Imaging Systems
- Headquarters: Durham, N.C.